GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹836 Cr | ₹779 Cr | ₹454 Cr | ₹306 Cr | ₹683 Cr |
What is the latest Profit Before Tax of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Profit Before Tax |
---|---|
Mar2023 | ₹836 Cr |
Mar2022 | ₹779 Cr |
Mar2021 | ₹454 Cr |
Mar2020 | ₹306 Cr |
Mar2019 | ₹683 Cr |
How is Profit Before Tax of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2023 | ₹836 Cr | 7.36 | |
Mar2022 | ₹779 Cr | 71.60 | |
Mar2021 | ₹454 Cr | 48.48 | |
Mar2020 | ₹306 Cr | -55.21 | |
Mar2019 | ₹683 Cr | - |
Compare Profit Before Tax of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹35,634.1 Cr | 1.9% | 8.3% | 67.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 1.9% |
8.3% |
67.7% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses